10x Genomics, Inc. (TXG) Revenue 2017–2025
10x Genomics, Inc. (TXG) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$642.8MFY2025 · since FY2017: $71.1M → $642.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $642.8M | +5.2% |
| FY2024 | $610.8M | -1.3% |
| FY2023 | $618.7M | +19.8% |
| FY2022 | $516.4M | +5.3% |
| FY2021 | $490.5M | +64.1% |
| FY2020 | $298.8M | +21.5% |
| FY2019 | $245.9M | +68.1% |
| FY2018 | $146.3M | +105.8% |
| FY2017 | $71.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice